Avantor, Inc. $AVTR Stake Lowered by Mutual of America Capital Management LLC

Mutual of America Capital Management LLC cut its stake in shares of Avantor, Inc. (NYSE:AVTRFree Report) by 3.3% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 338,879 shares of the company’s stock after selling 11,570 shares during the quarter. Mutual of America Capital Management LLC’s holdings in Avantor were worth $4,561,000 as of its most recent SEC filing.

Other institutional investors also recently made changes to their positions in the company. Swedbank AB grew its holdings in shares of Avantor by 71.4% during the second quarter. Swedbank AB now owns 102,514 shares of the company’s stock valued at $1,380,000 after purchasing an additional 42,700 shares during the last quarter. Fifth Third Bancorp grew its holdings in Avantor by 1,741.4% in the 2nd quarter. Fifth Third Bancorp now owns 73,141 shares of the company’s stock worth $984,000 after buying an additional 69,169 shares in the last quarter. Stanley Capital Management LLC grew its holdings in Avantor by 42.9% in the 1st quarter. Stanley Capital Management LLC now owns 998,500 shares of the company’s stock worth $16,186,000 after buying an additional 300,000 shares in the last quarter. Perpetual Ltd grew its holdings in Avantor by 3.5% in the 2nd quarter. Perpetual Ltd now owns 1,805,497 shares of the company’s stock worth $24,302,000 after buying an additional 60,823 shares in the last quarter. Finally, US Bancorp DE lifted its position in Avantor by 85.5% in the first quarter. US Bancorp DE now owns 11,135 shares of the company’s stock worth $180,000 after purchasing an additional 5,133 shares during the period. 95.08% of the stock is owned by institutional investors.

Analysts Set New Price Targets

A number of equities research analysts have weighed in on AVTR shares. Wells Fargo & Company cut their target price on Avantor from $19.00 to $16.00 and set an “overweight” rating for the company in a research report on Monday, August 4th. Barclays upped their target price on Avantor from $13.00 to $15.00 and gave the stock an “overweight” rating in a research report on Thursday, October 2nd. Morgan Stanley cut their target price on Avantor from $15.00 to $12.00 and set an “equal weight” rating for the company in a research report on Monday, August 4th. Evercore ISI cut their target price on Avantor from $18.00 to $16.00 and set an “outperform” rating for the company in a research report on Monday, August 4th. Finally, Jefferies Financial Group restated a “hold” rating on shares of Avantor in a research report on Friday, August 1st. Seven research analysts have rated the stock with a Buy rating and eight have assigned a Hold rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus target price of $15.81.

View Our Latest Report on AVTR

Insider Transactions at Avantor

In related news, CAO Steven W. Eck sold 3,476 shares of the stock in a transaction on Tuesday, August 5th. The stock was sold at an average price of $11.39, for a total transaction of $39,591.64. Following the completion of the sale, the chief accounting officer directly owned 55,068 shares in the company, valued at approximately $627,224.52. This trade represents a 5.94% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. 1.20% of the stock is currently owned by company insiders.

Avantor Price Performance

Shares of NYSE:AVTR opened at $15.17 on Thursday. Avantor, Inc. has a one year low of $10.82 and a one year high of $23.93. The stock has a fifty day moving average of $13.23 and a 200-day moving average of $13.35. The company has a market capitalization of $10.34 billion, a PE ratio of 15.32, a price-to-earnings-growth ratio of 5.09 and a beta of 0.98. The company has a debt-to-equity ratio of 0.48, a quick ratio of 0.67 and a current ratio of 0.98.

Avantor (NYSE:AVTRGet Free Report) last announced its earnings results on Friday, August 1st. The company reported $0.24 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.25 by ($0.01). Avantor had a net margin of 10.31% and a return on equity of 11.39%. The firm had revenue of $1.68 billion for the quarter, compared to analyst estimates of $1.67 billion. During the same period last year, the firm earned $0.25 earnings per share. Avantor’s revenue for the quarter was down 1.1% compared to the same quarter last year. As a group, equities analysts anticipate that Avantor, Inc. will post 1.06 EPS for the current fiscal year.

Avantor Company Profile

(Free Report)

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.

Featured Articles

Institutional Ownership by Quarter for Avantor (NYSE:AVTR)

Receive News & Ratings for Avantor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avantor and related companies with MarketBeat.com's FREE daily email newsletter.